Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Sprint Bioscience AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 67,695 Less Arrow 51,143 Less Arrow 79
Financial expenses 41 More Arrow 392 Less Arrow 1
Earnings before taxes -18,849 More Arrow -444 Less Arrow -56,916
EBITDA -19,296 More Arrow -403 Less Arrow -56,870
Total assets 43,371 More Arrow 63,190 Less Arrow 35,398
Current assets 38,409 More Arrow 58,626 Less Arrow 32,995
Current liabilities 33,809 More Arrow 35,054 Less Arrow 8,735
Equity capital 9,562 More Arrow 28,136 Less Arrow 26,663
- share capital 7,201 Less Arrow 7,073 Less Arrow 6,602
Employees (average) 37 Less Arrow 28 More Arrow 34

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 22.0% More Arrow 44.5% More Arrow 75.3%
Turnover per employee 1,830 Less Arrow 1,827 Less Arrow 2
Profit as a percentage of turnover -27.8% More Arrow -0.9% Less Arrow -72045.6%
Return on assets (ROA) -43.4% More Arrow -0.1% Less Arrow -160.8%
Current ratio 113.6% More Arrow 167.2% More Arrow 377.7%
Return on equity (ROE) -197.1% More Arrow -1.6% Less Arrow -213.5%
Change turnover 15,630 More Arrow 51,059 Less Arrow -33,136
Change turnover % 30% More Arrow 60725% Less Arrow -100%
Chg. No. of employees 9 Less Arrow -6 More Arrow 3
Chg. No. of employees % 32% Less Arrow -18% More Arrow 10%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.